Similarly, we did not find any evidence for the differential production of IL-10 by purified B cells from T1D patients following in-vitro stimulation with IL-21, which has been shown recently to drive the differentiation of IL-10-secreting effector CD19+CD27−CD24hiCD38hi regulatory B cells in mice 20. Here, CD19 is linked to type 1 diabetes mellitus.